Our work extends from the laboratory to wide-scale community studies with a focus on diagnosis, prevention and treatment of diabetes and cardiovascular disease.
Hosted by Matt Keenan, this webinar will feature Dr Liz Paratz, who is working to explain unexplained cardiac death.
Is exercise during chemotherapy helpful in protecting heart function?
Researchers at the Baker Institute and the University of Melbourne are taking the next steps in developing a new anti-inflammatory drug that could lessen the damage from heart attacks, extend the viability of transplanted organs, help treat autoimmune diseases such as multiple sclerosis, and even reduce fatal complications from viruses like COVID-19.
NLRP1 Obesity and diabetes ‘sensor’ protein identified.
IL-1 The discovery that fat in obese people causes the release of a molecule called IL-1.
Near-infrared fluorescence light can detect the atherosclerotic plaques that lead to heart attack and stroke.
Imaging athletes’ hearts during exercise, not at rest.
Biomarkers that highlight toxic fats in the liver.
Benefits for type 2 diabetes of interrupting prolonged sitting.
With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.Find out more